Long pages

From IDWiki

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Infection control precautions by disease ‎[26,583 bytes]
  2. (hist) ‎Skin and soft tissue infections (SSTI) (IDSA 2014) ‎[19,643 bytes]
  3. (hist) ‎Aspergillus ‎[19,072 bytes]
  4. (hist) ‎Mycobacterium tuberculosis ‎[17,842 bytes]
  5. (hist) ‎Creutzfeldt-Jakob disease ‎[17,524 bytes]
  6. (hist) ‎Plasmodium ‎[16,905 bytes]
  7. (hist) ‎Infective endocarditis ‎[16,718 bytes]
  8. (hist) ‎Tissue penetration of antimicrobials ‎[15,954 bytes]
  9. (hist) ‎Hepatitis B virus ‎[15,319 bytes]
  10. (hist) ‎Leishmania ‎[14,918 bytes]
  11. (hist) ‎Yeast and yeast-like organisms ‎[14,114 bytes]
  12. (hist) ‎Treponema pallidum pallidum ‎[13,933 bytes]
  13. (hist) ‎Non-tuberculous mycobacteria ‎[13,584 bytes]
  14. (hist) ‎Immunization ‎[13,496 bytes]
  15. (hist) ‎Candida ‎[13,249 bytes]
  16. (hist) ‎SARS-CoV-2 ‎[12,911 bytes]
  17. (hist) ‎Prosthetic joint infection ‎[12,771 bytes]
  18. (hist) ‎Taenia solium ‎[12,606 bytes]
  19. (hist) ‎Antifungal spectrum of activity ‎[12,538 bytes]
  20. (hist) ‎Human papillomavirus ‎[12,130 bytes]
  21. (hist) ‎Herpes simplex virus ‎[11,817 bytes]
  22. (hist) ‎Human immunodeficiency virus ‎[11,538 bytes]
  23. (hist) ‎Heparin ‎[11,406 bytes]
  24. (hist) ‎Borrelia burgdorferi ‎[11,285 bytes]
  25. (hist) ‎Pediatric dosing of antimicrobials ‎[11,219 bytes]
  26. (hist) ‎Hepatitis C virus ‎[11,203 bytes]
  27. (hist) ‎Histoplasma capsulatum ‎[11,133 bytes]
  28. (hist) ‎Echinococcus granulosus ‎[10,765 bytes]
  29. (hist) ‎Corynebacterium diphtheriae ‎[10,704 bytes]
  30. (hist) ‎Chronic heart failure ‎[10,671 bytes]
  31. (hist) ‎β-lactam allergy ‎[10,600 bytes]
  32. (hist) ‎Outpatient Parenteral Antimicrobial Therapy (OPAT) (IDSA 2018) ‎[10,532 bytes]
  33. (hist) ‎Renal dosing of antimicrobials ‎[10,414 bytes]
  34. (hist) ‎Viral hemorrhagic fever ‎[10,264 bytes]
  35. (hist) ‎Mucorales ‎[10,104 bytes]
  36. (hist) ‎HIV in pregnancy ‎[9,958 bytes]
  37. (hist) ‎Francisella tularensis ‎[9,936 bytes]
  38. (hist) ‎Leptospira ‎[9,743 bytes]
  39. (hist) ‎Virology ‎[9,660 bytes]
  40. (hist) ‎Infections after hematopoietic stem cell transplantation ‎[9,589 bytes]
  41. (hist) ‎Needlestick injuries and post-exposure prophylaxis ‎[9,374 bytes]
  42. (hist) ‎Invasive fungal infection ‎[9,271 bytes]
  43. (hist) ‎Congenital syphilis ‎[9,173 bytes]
  44. (hist) ‎Infective Endocarditis in Adults (IDSA 2015) ‎[9,085 bytes]
  45. (hist) ‎Measles virus ‎[9,029 bytes]
  46. (hist) ‎General principles of mycology ‎[9,006 bytes]
  47. (hist) ‎Varicella-zoster virus ‎[8,898 bytes]
  48. (hist) ‎Mycobacterium leprae ‎[8,851 bytes]
  49. (hist) ‎Listeria monocytogenes ‎[8,839 bytes]
  50. (hist) ‎Cytomegalovirus ‎[8,620 bytes]
  51. (hist) ‎Blastomyces dermatitidis ‎[8,596 bytes]
  52. (hist) ‎Strongyloides stercoralis ‎[8,495 bytes]
  53. (hist) ‎Pneumocystis jirovecii ‎[8,339 bytes]
  54. (hist) ‎Immunosuppressive therapy ‎[8,277 bytes]
  55. (hist) ‎Staphylococcus aureus bacteremia ‎[8,258 bytes]
  56. (hist) ‎Toxoplasma gondii ‎[8,160 bytes]
  57. (hist) ‎Clostridium botulinum ‎[8,080 bytes]
  58. (hist) ‎Bacterial meningitis ‎[8,077 bytes]
  59. (hist) ‎Outpatient Parenteral Antimicrobial Therapy (OPAT) (IDSA 2004) ‎[8,073 bytes]
  60. (hist) ‎Coccidioides immitis ‎[7,896 bytes]
  61. (hist) ‎Dimorphic fungi ‎[7,842 bytes]
  62. (hist) ‎Drug-drug interactions ‎[7,763 bytes]
  63. (hist) ‎Drive + Fly ‎[7,759 bytes]
  64. (hist) ‎Rabies virus ‎[7,733 bytes]
  65. (hist) ‎Hypertension ‎[7,709 bytes]
  66. (hist) ‎Streptococcus pyogenes ‎[7,588 bytes]
  67. (hist) ‎Latent tuberculosis infection ‎[7,493 bytes]
  68. (hist) ‎Epstein-Barr virus ‎[7,355 bytes]
  69. (hist) ‎Multidrug-resistant organism ‎[7,311 bytes]
  70. (hist) ‎Blood transfusion ‎[7,270 bytes]
  71. (hist) ‎Vibrio cholerae ‎[7,192 bytes]
  72. (hist) ‎Glomerulonephritis ‎[7,154 bytes]
  73. (hist) ‎Antimicrobial abbreviations ‎[7,148 bytes]
  74. (hist) ‎Wound care ‎[7,053 bytes]
  75. (hist) ‎Helicobacter pylori ‎[7,026 bytes]
  76. (hist) ‎Carbapenem-resistant organisms ‎[6,940 bytes]
  77. (hist) ‎Primary immunodeficiency ‎[6,842 bytes]
  78. (hist) ‎Pre-transplant screening ‎[6,825 bytes]
  79. (hist) ‎Fever in a returned traveller ‎[6,701 bytes]
  80. (hist) ‎Dementia ‎[6,666 bytes]
  81. (hist) ‎Osteomyelitis ‎[6,638 bytes]
  82. (hist) ‎Voriconazole ‎[6,531 bytes]
  83. (hist) ‎Adverse drug reaction ‎[6,464 bytes]
  84. (hist) ‎Coxiella burnetii ‎[6,436 bytes]
  85. (hist) ‎Variola virus ‎[6,416 bytes]
  86. (hist) ‎Infection prevention and control program ‎[6,408 bytes]
  87. (hist) ‎Asthma ‎[6,380 bytes]
  88. (hist) ‎Trypanosoma brucei ‎[6,365 bytes]
  89. (hist) ‎Native vertebral osteomyelitis (IDSA 2015) ‎[6,319 bytes]
  90. (hist) ‎Chlamydia trachomatis ‎[6,231 bytes]
  91. (hist) ‎Osteoporosis ‎[6,191 bytes]
  92. (hist) ‎CCU drugs and concentrations ‎[6,115 bytes]
  93. (hist) ‎β-lactamases ‎[6,099 bytes]
  94. (hist) ‎Mumps virus ‎[6,072 bytes]
  95. (hist) ‎Kaposi sarcoma ‎[6,059 bytes]
  96. (hist) ‎Pelvic inflammatory disease ‎[6,021 bytes]
  97. (hist) ‎Mycobacterium avium complex ‎[5,968 bytes]
  98. (hist) ‎Rickettsioses ‎[5,919 bytes]
  99. (hist) ‎Antibiotic spectrum index ‎[5,908 bytes]
  100. (hist) ‎Prosthetic joint infections (PJI) (IDSA 2013) ‎[5,908 bytes]
  101. (hist) ‎Acute heart failure ‎[5,807 bytes]
  102. (hist) ‎Mpox virus ‎[5,765 bytes]
  103. (hist) ‎Vancomycin ‎[5,754 bytes]
  104. (hist) ‎Streptococcus bacteremia ‎[5,697 bytes]
  105. (hist) ‎Ventriculitis ‎[5,576 bytes]
  106. (hist) ‎Intrinsic antibiotic resistance ‎[5,514 bytes]
  107. (hist) ‎Clostridioides difficile ‎[5,512 bytes]
  108. (hist) ‎Rickettsia rickettsii ‎[5,495 bytes]
  109. (hist) ‎Tropheryma whipplei ‎[5,466 bytes]
  110. (hist) ‎How to do an HIV consult ‎[5,450 bytes]
  111. (hist) ‎Antimicrobial stewardship program ‎[5,444 bytes]
  112. (hist) ‎SPRINT Frailty Index ‎[5,406 bytes]
  113. (hist) ‎Intravascular catheter-related infections (IDSA 2009) ‎[5,370 bytes]
  114. (hist) ‎Sterilization and disinfection ‎[5,328 bytes]
  115. (hist) ‎Mediastinitis ‎[5,318 bytes]
  116. (hist) ‎Hepatitis A virus ‎[5,310 bytes]
  117. (hist) ‎Colistin ‎[5,296 bytes]
  118. (hist) ‎Acute stroke ‎[5,287 bytes]
  119. (hist) ‎Cardiovascular implantable electronic device infection ‎[5,271 bytes]
  120. (hist) ‎Biosafety risk groups ‎[5,257 bytes]
  121. (hist) ‎Trypanosoma cruzi ‎[5,254 bytes]
  122. (hist) ‎Antiretroviral resistance in HIV ‎[5,231 bytes]
  123. (hist) ‎Acute kidney injury ‎[5,179 bytes]
  124. (hist) ‎Bronchiectasis ‎[5,108 bytes]
  125. (hist) ‎HIV treatment ‎[5,095 bytes]
  126. (hist) ‎Streptococcus pneumoniae ‎[5,089 bytes]
  127. (hist) ‎Cardiovascular implantable electronic device (CIED) (IDSA 2017) ‎[5,058 bytes]
  128. (hist) ‎Culture media ‎[4,997 bytes]
  129. (hist) ‎Dosing of antimicrobials in obesity ‎[4,957 bytes]
  130. (hist) ‎Chronic active Epstein-Barr virus disease ‎[4,922 bytes]
  131. (hist) ‎Congenital CMV ‎[4,883 bytes]
  132. (hist) ‎Non-typhoidal Salmonella ‎[4,864 bytes]
  133. (hist) ‎Sporothrix schenckii ‎[4,851 bytes]
  134. (hist) ‎Ehrlichia ‎[4,821 bytes]
  135. (hist) ‎Myelopathy ‎[4,816 bytes]
  136. (hist) ‎Bordetella pertussis ‎[4,815 bytes]
  137. (hist) ‎Pancytopenia ‎[4,810 bytes]
  138. (hist) ‎Glycogen storage disease ‎[4,794 bytes]
  139. (hist) ‎Tick-borne infections ‎[4,770 bytes]
  140. (hist) ‎Healthcare-associated ventriculitis and meningitis (IDSA 2017) ‎[4,757 bytes]
  141. (hist) ‎Neisseria gonorrhoeae ‎[4,741 bytes]
  142. (hist) ‎C-reactive protein ‎[4,735 bytes]
  143. (hist) ‎Falls in the elderly ‎[4,689 bytes]
  144. (hist) ‎Vaccine-preventable diseases ‎[4,675 bytes]
  145. (hist) ‎Lymphadenopathy ‎[4,656 bytes]
  146. (hist) ‎Hypertension in pregnancy ‎[4,597 bytes]
  147. (hist) ‎Chronic kidney disease ‎[4,591 bytes]
  148. (hist) ‎Stimulant use disorder ‎[4,585 bytes]
  149. (hist) ‎Helminths ‎[4,572 bytes]
  150. (hist) ‎Brucella melitensis ‎[4,549 bytes]
  151. (hist) ‎Cryptosporidium hominis ‎[4,528 bytes]
  152. (hist) ‎Post-exposure prophylaxis for HIV ‎[4,506 bytes]
  153. (hist) ‎Tick-borne relapsing fever ‎[4,505 bytes]
  154. (hist) ‎Legionella ‎[4,500 bytes]
  155. (hist) ‎Acute rheumatic fever ‎[4,498 bytes]
  156. (hist) ‎Approach to Clinical Syndromes: Part I ‎[4,483 bytes]
  157. (hist) ‎Central line-associated bloodstream infection ‎[4,471 bytes]
  158. (hist) ‎Mycetoma ‎[4,468 bytes]
  159. (hist) ‎Human T-lymphotropic virus ‎[4,435 bytes]
  160. (hist) ‎Pseudomonas aeruginosa ‎[4,419 bytes]
  161. (hist) ‎Mycology lab safety ‎[4,407 bytes]
  162. (hist) ‎Revised Clinical Institute Withdrawal Assessment for alcohol ‎[4,390 bytes]
  163. (hist) ‎Idiopathic intracranial hypertension ‎[4,375 bytes]
  164. (hist) ‎Hantavirus ‎[4,371 bytes]
  165. (hist) ‎Subarachnoid hemorrhage ‎[4,371 bytes]
  166. (hist) ‎Urinary tract infection ‎[4,325 bytes]
  167. (hist) ‎Alcohol withdrawal ‎[4,315 bytes]
  168. (hist) ‎HIV-hepatitis C coinfection ‎[4,301 bytes]
  169. (hist) ‎Brain abscess ‎[4,301 bytes]
  170. (hist) ‎Neonatal HIV ‎[4,292 bytes]
  171. (hist) ‎Nocardia ‎[4,287 bytes]
  172. (hist) ‎Toxoplasmosis in pregnancy ‎[4,273 bytes]
  173. (hist) ‎Carbapenemases ‎[4,271 bytes]
  174. (hist) ‎HIV medications ‎[4,266 bytes]
  175. (hist) ‎Pulmonary tuberculosis ‎[4,257 bytes]
  176. (hist) ‎Neonatal HSV ‎[4,240 bytes]
  177. (hist) ‎Corynebacterium ‎[4,229 bytes]
  178. (hist) ‎Trimethoprim-sulfamethoxazole ‎[4,228 bytes]
  179. (hist) ‎Pre-exposure prophylaxis for HIV ‎[4,213 bytes]
  180. (hist) ‎Tuberculous meningitis ‎[4,198 bytes]
  181. (hist) ‎Buprenorphine ‎[4,176 bytes]
  182. (hist) ‎Benzodiazepine use disorder ‎[4,111 bytes]
  183. (hist) ‎Cystic fibrosis ‎[4,107 bytes]
  184. (hist) ‎Streptococcal toxic shock syndrome ‎[4,103 bytes]
  185. (hist) ‎Chronic obstructive pulmonary disease ‎[4,101 bytes]
  186. (hist) ‎Burkholderia pseudomallei ‎[4,088 bytes]
  187. (hist) ‎HIV prevention ‎[4,074 bytes]
  188. (hist) ‎CSF pleocytosis ‎[4,072 bytes]
  189. (hist) ‎COVID-19-associated pulmonary aspergillosis ‎[4,043 bytes]
  190. (hist) ‎Hepatitis B vaccine ‎[4,029 bytes]
  191. (hist) ‎Crohn disease ‎[4,016 bytes]
  192. (hist) ‎Amyotrophic lateral sclerosis ‎[4,009 bytes]
  193. (hist) ‎Gastroenteritis ‎[4,009 bytes]
  194. (hist) ‎Drug-resistant tuberculosis ‎[4,006 bytes]
  195. (hist) ‎Cannabis use disorder ‎[3,989 bytes]
  196. (hist) ‎Streptobacillus moniliformis ‎[3,974 bytes]
  197. (hist) ‎Shorter is better ‎[3,969 bytes]
  198. (hist) ‎Modified Jones criteria ‎[3,969 bytes]
  199. (hist) ‎Venous thromboembolism ‎[3,964 bytes]
  200. (hist) ‎Interstitial cystitis ‎[3,952 bytes]
  201. (hist) ‎Type 2 diabetes mellitus ‎[3,874 bytes]
  202. (hist) ‎CMV after solid organ transplantation ‎[3,851 bytes]
  203. (hist) ‎Chromoblastomycosis ‎[3,827 bytes]
  204. (hist) ‎Intestinal protozoa ‎[3,820 bytes]
  205. (hist) ‎Normal labour and delivery ‎[3,810 bytes]
  206. (hist) ‎Hereditary hemorrhagic telangiectasia ‎[3,810 bytes]
  207. (hist) ‎Babesia microti ‎[3,809 bytes]
  208. (hist) ‎Clostridium tetani ‎[3,797 bytes]
  209. (hist) ‎Giardia lamblia ‎[3,784 bytes]
  210. (hist) ‎Chronic meningitis ‎[3,771 bytes]
  211. (hist) ‎Sarcoptes scabiei ‎[3,726 bytes]
  212. (hist) ‎Immunization after hematopoietic stem cell transplantation ‎[3,721 bytes]
  213. (hist) ‎Bartonella henselae ‎[3,718 bytes]
  214. (hist) ‎Dematiaceous molds ‎[3,710 bytes]
  215. (hist) ‎Dermatophytes ‎[3,699 bytes]
  216. (hist) ‎CMV in pregnancy ‎[3,692 bytes]
  217. (hist) ‎Aminoglycosides ‎[3,688 bytes]
  218. (hist) ‎Drug fever ‎[3,677 bytes]
  219. (hist) ‎Multisystem inflammatory syndrome in children ‎[3,672 bytes]
  220. (hist) ‎Acute exacerbation of COPD ‎[3,670 bytes]
  221. (hist) ‎Yellow fever virus ‎[3,660 bytes]
  222. (hist) ‎Refeeding syndrome ‎[3,653 bytes]
  223. (hist) ‎Familial Mediterranean fever ‎[3,638 bytes]
  224. (hist) ‎Disseminated intravascular coagulation ‎[3,638 bytes]
  225. (hist) ‎Respiratory syncytial virus ‎[3,620 bytes]
  226. (hist) ‎BK virus ‎[3,619 bytes]
  227. (hist) ‎Respiratory infection in a returned traveller ‎[3,600 bytes]
  228. (hist) ‎Perioperative assessment ‎[3,593 bytes]
  229. (hist) ‎Enterovirus ‎[3,586 bytes]
  230. (hist) ‎Schistosoma ‎[3,581 bytes]
  231. (hist) ‎​ASA Physical Status Classification System ‎[3,580 bytes]
  232. (hist) ‎Routine follow-up for patients with HIV ‎[3,574 bytes]
  233. (hist) ‎Secondary hemolytic-uremic syndrome ‎[3,568 bytes]
  234. (hist) ‎Autism spectrum disorder ‎[3,558 bytes]
  235. (hist) ‎Sarcoidosis ‎[3,557 bytes]
  236. (hist) ‎Vaccination after hematopoietic stem cell transplantation ‎[3,554 bytes]
  237. (hist) ‎Vascular graft infection ‎[3,523 bytes]
  238. (hist) ‎Neisseria meningitidis ‎[3,521 bytes]
  239. (hist) ‎Non-resolving pneumonia ‎[3,494 bytes]
  240. (hist) ‎Common variable immunodeficiency ‎[3,485 bytes]
  241. (hist) ‎Program evaluation ‎[3,472 bytes]
  242. (hist) ‎Recurrent urinary tract infection ‎[3,468 bytes]
  243. (hist) ‎Macacine alphaherpesvirus 1 ‎[3,457 bytes]
  244. (hist) ‎Bacterial vaginosis ‎[3,447 bytes]
  245. (hist) ‎Campylobacter ‎[3,446 bytes]
  246. (hist) ‎Slow-release oral morphine ‎[3,441 bytes]
  247. (hist) ‎Respiratory infection in an immunocompromised person ‎[3,435 bytes]
  248. (hist) ‎Preeclampsia ‎[3,408 bytes]
  249. (hist) ‎Nodular lymphangitis ‎[3,406 bytes]
  250. (hist) ‎Fosfomycin ‎[3,401 bytes]

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)